Lange SMM, Schirmbeck F, Stek ML, Murk Jansen YR, van Rooijen G, de Haan L, Penninx B, Rhebergen D, Investigators G (2021) A comparison of depressive symptom profiles between current major depressive disorder and schizophrenia spectrum disorder. J Psychiatr Res 135:143–151
Kanchanatawan B, Sirivichayakul S, Thika S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Noto C, Ivanova R, Maes M (2017) Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway. Metab Brain Dis 32:1003–1016
Article CAS PubMed Google Scholar
Fritze S, Sambataro F, Kubera KM, Brandt GA, Meyer-Lindenberg A, Wolf RC, Hirjak D (2022) Characterizing the sensorimotor domain in schizophrenia spectrum disorders. Eur Arch Psychiatry Clin Neurosci 272:1097–1108
Arias JA, Williams C, Raghvani R, Aghajani M, Baez S, Belzung C, Booij L, Busatto G, Chiarella J, Fu CH, Ibanez A, Liddell BJ, Lowe L, Penninx B, Rosa P, Kemp AH (2020) The neuroscience of sadness: a multidisciplinary synthesis and collaborative review. Neurosci Biobehav Rev 111:199–228
Article CAS PubMed Google Scholar
Kovacs LN, Takacs ZK, Toth Z, Simon E, Schmelowszky A, Kokonyei G (2020) Rumination in major depressive and bipolar disorder—a meta-analysis. J Affect Disord 276:1131–1141
Chen L, Wang Q, Xu T (2023) Working memory function in patients with major depression disorder: a narrative review. Clin Psychol Psychother 30:281–293
van Eeden WA, van Hemert AM, Carlier IVE, Penninx BW, Spinhoven P, Giltay EJ (2019) Neuroticism and chronicity as predictors of 9-year course of individual depressive symptoms. J Affect Disord 252:484–492
Oliva V, Fanelli G, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Kas MJ, De Ronchi D, Fabbri C, Serretti A (2022) Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts. Int Clin Psychopharmacol 37:38–45
Song XM, Hu XW, Li Z, Gao Y, Ju X, Liu DY, Wang QN, Xue C, Cai YC, Bai R, Tan ZL, Northoff G (2021) Reduction of higher-order occipital gaba and impaired visual perception in acute major depressive disorder. Mol Psychiatry 26:6747–6755
Article CAS PubMed PubMed Central Google Scholar
Walther S, Bernard JA, Mittal VA, Shankman SA (2019) The utility of an rdoc motor domain to understand psychomotor symptoms in depression. Psychol Med 49:212–216
Article CAS PubMed Google Scholar
Fonseca-Pedrero E (2017) Network analysis: a new way of understanding psychopathology? Rev Psiquiatr Salud Ment 10:206–215
Jones PJ, Heeren A, McNally RJ (2017) Commentary: a network theory of mental disorders. Front Psychol 8:1305
Article PubMed PubMed Central Google Scholar
Borsboom D (2017) A network theory of mental disorders. World Psychiatry 16:5–13
Article PubMed PubMed Central Google Scholar
Abplanalp SJ, Braff DL, Light GA, Nuechterlein KH, Green MF, Consortium on the Genetics of S (2022) Understanding connections and boundaries between positive symptoms, negative symptoms, and role functioning among individuals with schizophrenia: a network psychometric approach. JAMA Psychiat 79:1014–1022
Abplanalp SJ, Mueser KT, Fulford D (2022) The centrality of motivation in psychosocial functioning: network and bifactor analysis of the quality of life scale in first-episode psychosis. Psychol Assess 34:205–216
Dal Santo F, Fonseca-Pedrero E, Garcia-Portilla MP, Gonzalez-Blanco L, Saiz PA, Galderisi S, Giordano GM, Bobes J (2022) Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: a network analysis from the optimise trial. Eur Psychiatry 65:e33
Strauss GP, Esfahlani FZ, Galderisi S, Mucci A, Rossi A, Bucci P, Rocca P, Maj M, Kirkpatrick B, Ruiz I, Sayama H (2019) Network analysis reveals the latent structure of negative symptoms in schizophrenia. Schizophr Bull 45:1033–1041
Galderisi S, Rucci P, Kirkpatrick B, Mucci A, Gibertoni D, Rocca P, Rossi A, Bertolino A, Strauss GP, Aguglia E, Bellomo A, Murri MB, Bucci P, Carpiniello B, Comparelli A, Cuomo A, De Berardis D, Dell’Osso L, Di Fabio F, Gelao B, Marchesi C, Monteleone P, Montemagni C, Orsenigo G, Pacitti F, Roncone R, Santonastaso P, Siracusano A, Vignapiano A, Vita A, Zeppegno P, Maj M, Italian Network for Research on P (2018) Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis. JAMA Psychiat 75:396–404
Sambataro F, Fritze S, Rashidi M, Topor CE, Kubera KM, Wolf RC, Hirjak D (2020) Moving forward: distinct sensorimotor abnormalities predict clinical outcome after 6 months in patients with schizophrenia. Eur Neuropsychopharmacol 36:72–82
Article CAS PubMed Google Scholar
Herold CJ, Duval CZ, Schröder J (2021) Neurological soft signs and cognition in the late course of chronic schizophrenia: a longitudinal study. Eur Arch Psychiatry Clin Neurosci 271:1465–1473
Bachmann S, Schröder J (2017) Neurological soft signs in schizophrenia: an update on the state- versus trait-perspective. Front Psych 8:272
Valerio MP, Lomastro J, Igoa A, Martino DJ (2023) Correlates of neurological soft signs in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 273:1183–1190
Schröder J, Niethammer R, Geider FJ, Reitz C, Binkert M, Jauss M, Sauer H (1991) Neurological soft signs in schizophrenia. Schizophr Res 6:25–30
Hurford IM, Marder SR, Keefe RS, Reise SP, Bilder RM (2011) A brief cognitive assessment tool for schizophrenia: construction of a tool for clinicians. Schizophr Bull 37:538–545
Zhao Q, Li Z, Huang J, Yan C, Dazzan P, Pantelis C, Cheung EF, Lui SS, Chan RC (2014) Neurological soft signs are not “soft” in brain structure and functional networks: evidence from ale meta-analysis. Schizophr Bull 40:626–641
Walther S, van Harten PN, Waddington JL, Cuesta MJ, Peralta V, Dupin L, Foucher JR, Sambataro F, Morrens M, Kubera KM, Pieters LE, Stegmayer K, Strik W, Wolf RC, Hirjak D (2020) Movement disorder and sensorimotor abnormalities in schizophrenia and other psychoses—European consensus on assessment and perspectives. Eur Neuropsychopharmacol 38:25–39
Article CAS PubMed Google Scholar
Pavlidou A, Walther S (2020) Using virtual reality as a tool in the rehabilitation of movement abnormalities in schizophrenia. Front Psychol 11:607312
Sass H, Wittchen HU, Zaudig M, IH (2003) Diagnostisches und statistisches Manual psychischer Störungen DSM-IV-TR: Textrevision. Hogrefe Verlag; Auflage: 1 (1. Januar 2003)
Hirjak D, Kubera KM, Northoff G, Fritze S, Bertolino AL, Topor CE, Schmitgen MM, Wolf RC (2019) Cortical contributions to distinct symptom dimensions of catatonia. Schizophr Bull 45:1184–1194
Article PubMed PubMed Central Google Scholar
Hirjak D, Rashidi M, Kubera KM, Northoff G, Fritze S, Schmitgen MM, Sambataro F, Calhoun VD, Wolf RC (2019) Multimodal magnetic resonance imaging data fusion reveals distinct patterns of abnormal brain structure and function in catatonia. Schizophrenia Bull 46:202–210
Otte ML, Schmitgen MM, Kubera KM, Wolf ND, Fritze S, Geiger LS, Tost H, Seidl UW, Meyer-Lindenberg A, Hirjak D, Wolf RC (2022) Cortical morphology and illness insight in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 272(6):985–995. https://doi.org/10.1007/s00406-021-01328-x
Sambataro F, Hirjak D, Fritze S, Kubera KM, Northoff G, Calhoun VD, Meyer-Lindenberg A, Wolf RC (2021) Intrinsic neural network dynamics in catatonia. Hum Brain Mapp 42(18):6087–6098. https://doi.org/10.1002/hbm.25671
Article PubMed PubMed Central Google Scholar
Margraf J, Schneider S, Ehlers A, Psychologie C-D-SFK (1994) Diagnostisches interview bei psychischen störungen: dips. Springer
Leucht S, Samara M, Heres S, Patel MX, Furukawa T, Cipriani A, Geddes J, Davis JM (2015) Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method. Schizophr Bull 41:1397–1402
Article PubMed PubMed Central Google Scholar
Hayasaka Y, Purgato M, Magni LR, Ogawa Y, Takeshima N, Cipriani A, Barbui C, Leucht S, Furukawa TA (2015) Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J Affect Disord 180:179–184
Article CAS PubMed Google Scholar
Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (panss) for schizophrenia. Schizophr Bull 13:261–276
Article CAS PubMed Google Scholar
Dsm-iiiR (1989) Dkudddusmpsr gaf-skala: global assessment of functioning scale. Beltz, Weinheim, Basel
Amieva H, Meillon C, Proust-Lima C, Dartigues JF (2019) Is low psychomotor speed a marker of brain vulnerability in late life? Digit symbol substitution test in the prediction of Alzheimer, Parkinson, stroke, disability, and depression. Dement Geriatr Cogn Disord 47:297–305
Boylu ME, Turan S, Guler EM, Boylu FB, Kilic O, Kocyigit A, Kirpinar I (2023) Changes in neuroactive steroids, neurotrophins and immunological biomarkers after monotherapy 8-week rtms treatment and their relationship with neurocognitive functions in depression. Eur Arch Psychiatry Clin Neurosci. https://doi.org/10.1007/s00406-023-01704-9
留言 (0)